Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FT6AH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,120
Award facts
- Contract value 100% obligated
- $26,119.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,119.78 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on September 8, 2025, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills a significant role in supporting the Defense Health Agency and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's demonstrated capability to compete successfully across multiple therapeutic domains and transaction values positions it as a key supplier within DLA's pharmaceutical supply chain, which supports military personnel and veteran healthcare needs globally. This specific delivery order for RINVOQ ER reflects the company's continued participation in routine pharmaceutical procurement operations under its prime vendor contract framework.
Quick answers
Who was awarded contract SPE2DB25FT6AH?
SPE2DB25FT6AH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FT6AH worth?
The government has obligated $26,120 on SPE2DB25FT6AH.
Is contract SPE2DB25FT6AH an order under another contract?
Yes. SPE2DB25FT6AH is a delivery order under SPE2DB22D3401, an indefinite delivery contract.
Was contract SPE2DB25FT6AH competed?
The extent of competition for SPE2DB25FT6AH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award